Electroretinographic (ERG) responses in pediatric patients using vigabatrin

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• Vigabatrin (VGB) is an antiepileptic drug known to cause visual dysfunction.
• Electroretinography (ERG) is used to assess visual function, particularly in patients unable to undergo standard perimetry.

Purpose of the Study:

• To evaluate the utility of ERG in detecting vigabatrin-induced visual toxicity in pediatric patients.
• To compare ERG findings with visual field defects in children treated with VGB.

Main Methods:

• 114 pediatric patients on VGB underwent ERG testing under scotopic and photopic conditions.
• ERG responses were compared to healthy controls.
• Longitudinal testing was performed on 27 patients.
• A subset of patients (N=39) also underwent perimetry.

Main Results:

• Abnormalities in photoreceptor and post-receptor ERG responses were common in pediatric patients on VGB.
• The most frequent abnormalities were reduced post-receptor sensitivity (log σ) in scotopic conditions and prolonged OFF response implicit time (d-wave) in photopic conditions.
• Abnormal 30-Hz flicker response amplitude was infrequent.
• No significant association was found between ERG parameters and visual field defects in the subset of patients tested.

Conclusions:

• ERG can detect retinal abnormalities in pediatric patients using VGB, but may not be a reliable predictor of visual field loss.
• The study highlights potential limitations of ERG for monitoring VGB toxicity in children.
• Further development of reliable peripheral vision tests is recommended to better assess VGB-related visual side effects.